Ajanta Pharma is the fastest-growing Indian pharmaceutical company. It is engaged in producing, manufacturing, and marketing quality medications.
Committed to ‘Serve Health Care Needs Worldwide,’ they develop a wide range of specialty-branded generic products targeting various therapeutic segments, including dermatology, ophthalmology, pain management, and cardiology.
Recently, Ajanta Pharma Ltd. also got into two new therapies of nephrology and gynecology.
Ajanta Pharma was established in 1973 in India and has since moved up the value chain from a small manufacturer to a large, marketing and research-oriented company. The company operates in India, the United States, Africa, Asia, and internationally [1] [2] [3].
Key Points
Key facts: It is headquartered in Mumbai, Maharashtra; it is listed on the BSE and NSE.
Operations and Resources: Has seven manufacturing facilities in India. Two facilities are approved by the FDA, while others are WHO-cGMP compliant.
Market and Significance: Ajanta Pharma serves over 30 countries across the Middle East, Southeast Asia, Central Asia, and Africa.
Business Model: Diversified across branded generics (India, Asia, Africa), selective US generics, and African institutional (antimalarial) business, with a strong field force and a profitability-focused selective US strategy.
Revenue Breakdown (FY2025 Annual): Total Revenue: ₹4,648 crore.
Human Resources: 11,000+ employees, 5,400+ MRs [4].
Top Executives
The top executives of Ajanta Pharma are [5]:
| Name | Title |
| Mannalal Bhagwandas Agrawal | Chairman of the board |
| Rajesh Mannalal Agrawal | Joint MD and Director |
| Yogesh Mannalal Agrawal | MD and Executive Director |
| Madhusudan Bhagwandas Agrawal | Executive Vice Chairman of the Board |
| Rajesh Shashikant Dalal | Independent Non-Executive Director |
| Medha Vinay Joshi | Independent Non-Executive Director |
| Simi Manohar Lal Thapar | Independent Non-Executive Director |
| Suttian Deerpaul | Director of Ajanta Pharma (Mauritius) Ltd. |
| Ramesh C. Jhawar | Director of Ajanta Pharma USA Inc. |
| Vinayak Muzumdar | Director of Ajanta Pharma (Mauritius) Ltd. |
Contact Information
Address: Ajanta Tower 54A, M.V. Road Chakala, Mumbai, 400 093, India
Phone Number: 91 22 6060 9000
Website: www.ajantapharma.com
Other Information
| Company type | Pharma |
| Industry | Pharmaceuticals |
| Sub-industry | Specialty generics |
| Ownership | Public |
| Status | Operating |
| Modalities | Small molecules, oral solids, ophthalmic solutions, topicals, and injectables. |
Ajanta Pharma Products At Vedi Care Health
Vedi Care Health is a trusted online pharmaceutical supply platform that offers a wide range of pharmaceutical products from leading manufacturers, including Ajanta Pharma. Our platform is committed to providing customers with quality medications at affordable prices while ensuring a convenient online shopping experience.
One of the most popular Ajanta Pharma products available at Vedi Care Health is Kamagra Oral Jelly. This sildenafil citrate-based medication is designed to help men with erectile dysfunction (ED) by improving blood flow to the penis. Erectile dysfunction is a condition in which a man finds it difficult to achieve and sustain an erection.
Kamagra Oral Jelly is easy to consume without water and is often chosen by individuals who have difficulty swallowing pills. It is available in single-use sachets and comes in different flavor options.
Note: Kamagra Oral Jelly should only be taken after consulting a healthcare professional. A doctor can determine whether this medication is appropriate based on your medical history, current health condition, and any other medications you may be taking
References
- Ajanta Pharma Ltd., Devex
- About | Ajanta Pharma, Ajanta Pharma USA
- Ajanta Pharma, Wikipedia
- About Ajanta Pharma: Company Information, Overview, History and Profile, Trendlyne
- Ajanta Pharma Ltd. investing
